1581 Dodd Dr
Columbus, OH 43210
Associate Professor, Endo, Diabetes & Metabolism
Physician, FGP-Endo-Diabetes & Metabolism
Mr. Fuller is a co-author on a manuscript that was submitted in 2012.
|present||Medical: State Medical Board of Ohio|
|- 2004||Board Certification: American Board of Internal Medicine|
|- 2006||Board Certification: American Board of Internal Medicine|
Dungan KM, Buse JB. "Management of Type 2 Diabetes." In Endocrinology. Edited by DeGroot & Jameson. -. January 0.
Dr. Kathleen Marie Dungan, Harris E, Braithwaite S.. "Type 2 diabetes and concomitant illness: the prepared practice." In Type 2 Diabetes Mellitus: An Evidence-Based Approach to Practical Management. Edited by Feinglos M. and Bethel M.A.. -. Totowa, NJ: Humana Press, January 2007.
Kathleen Dungan. "Rationale for Management of Hyperglycemia.." In Therapy for Diabetes Mellitus and Related Disorders.. Edited by Harold E Lebovitz. -. Alexandria: American Diabetes Association, January 2009.
Dungan, Kathleen. "GLP-1-based therapies for the treatment of diabetes." In UpToDate. Edited by Rose, BD. -. Wellesley, Mass: Rose, BD, January 2010.
Kathleen Marie Dungan. "Amylin Analogues for the treatment of diabetes." In UpToDate. Edited by Rose, BD. -. Wellesley, MA: UpToDate, January 2010.
|01/01/2010 - 06/01/2012||Continuous Glucose Monitoring Interpretation (OSU Carepoint East)|
|1997||B.S., The Ohio State University|
|2001||M.D., The Ohio State University|
|2012||M.Public Hlth., The Ohio State University|
|2007 - present||Diabetes Care|
|2008 - 2011||The Open Diabetes Journal|
|2009||Journal of Parenteral and Enteral Nutrition|
|2009||Diabetes Research and Clinical Practice|
|2009 - 2010||Critical Care Medicine|
|2009 - 2012||Lancet|
|2010||Journal of Clinical Endocrinology & Metabolism|
|2010||ADA 70th Annual Scientific Sessions 2010,|
|2012||Diabetes Technology and Therapeutics|
|2012||ADA Scientific Sessions 2012 Organizing Committee|
|2001||Alpha Omega Alpha. Alpha Omega Alpha.|
|2006||AACE Thyroid Ultrasound and FNA biopsy Accreditation.|
|2006||ISCD Certified Clinical Densitometrist.|
|2009||Med II Endocrinology Block Teaching Award. The Ohio State University College of Medicine.|
|2009||Med I/II Integrated Pathway Endocrinology Moldule Teaching Award.|
|2009 - 2012||Best Doctors in America. Best Doctors.|
|2010||Columbus Monthly Best Doctors.|
|2012||CCTS Poster Award. OSU CCTS.|
Dungan KM. "The effect of diabetes on hospital readmissions." Journal of Diabetes Science & Technology. (January 0.): -.
Dungan KM. "Global Cardiovascular Risk in Diabetes." Endocrine Today. (January 0.): -.
Gassner, K, M; Tassava, R A. "Abnormal limb regeneration in the short-toes mutant of the axolotl, Ambystoma mexicanum: studies of age, level of amputation, and extracellular matrix.." The Journal of experimental zoology. Vol. 279, no. 6. (January 1997.): 571-8.
Dungan, Kathleen, M; Wei, Timothy, Y; Nace, Jackie, D; Poulin, Matthew, L; Chiu, Ing-Ming; Lang, James, C; Tassava, Roy A. "Expression and biological effect of urodele fibroblast growth factor 1: relationship to limb regeneration.." The Journal of experimental zoology. Vol. 292, no. 6. (January 2002.): 540-54.
Kathleen Dungan and John Buse. "Exenatide and GLP-1: novel treatment options for type 2 diabetes." Diabetic Microvascular Complications Today. (March 2005.): -.
Kathleen Dungan and John Buse. "Glucagon-like peptide 1-based therapies for type 2 diabetes: a focus on Exenatide." Clinical Diabetes. Vol. 23, no. 2. (January 2005.): 52-62.
Dungan, Kathleen, M; Buse, John, B; Largay, Joseph; Kelly, Mary, M; Button, Eric, A; Kato, Shuhei; Wittlin, Steven. "1,5-anhydroglucitol and postprandial hyperglycemia as measured by continuous glucose monitoring system in moderately controlled patients with diabetes.." Diabetes care. Vol. 29, no. 6. (January 2006.): 1214-9.
Kathleen Dungan. "Treating Diabetes by Modifying GLP-1 Activity: Current Options and New Developments." Diabetic Microvascular Complications Today. (May 2006.): -.
Kathleen Dungan. "Glucose measurement in the hospital: Tips for clinicians." Review of Endocrinology. Vol. May 2007, (May 2007.): 16-19.
Dungan K, Guster T, DeWalt D, Buse J. "A Comparison of Lipid and Lipoprotein Measurements in the Fasting and Nonfasting States in Patients with Type 2 Diabetes." Current Medical Research and Opinion. Vol. 23, no. 11. (January 2007.): 2689-2695.
Dungan KM, Chapman J, Braithwaite SS, Buse J. "Glucose measurement: confounding issues in setting targets for inpatient management.." Diabetes care. Vol. 30, no. 2. (January 2007.): 403-9.
Ali NA, O’Brien JM, Dungan K, Phillips G, Marsh CB, Lemeshow S, Connors AF, Preiser JC. "Glucose variability and mortality in patients with sepsis." Crit Care Med 2008. Vol. 36, no. 8. (January 2008.): 2316-2321.
Kathleen Dungan. "Significance of glucose excursions in hospitalized patients." Endocrine Today. (January 2008.): -.
Schneider A, Neas L, Herbst MC, Williams RW, Cascio W, Hinderliter A, Holguin F, Buse J, Dungan K, Styner M, Peters A, Devlin RB. "Endothelial Dysfunction: Associations with Exposure to Ambient Fine Particles in Diabetic Subjects." Environmental Health Perspectives. Vol. 116, no. 12. (January 2008.): 1666-1674.
Dungan K. "Is the A1C enough for monitoring glycemic control? 1,5-anhydroglucitol as a marker of short-term glycemic control and glycemic excursions.." Expert Reviews in Molecular Diagnostics. Vol. 8, no. 1. (January 2008.): 9-19.
Herman WH, Dungan KM, Wolffenbuttel BHR, Buse JB, Fahrbach J, Jiang H, Martin S.. "Racial and Ethnic Differences in Mean Plasma Glucose, A1c, and 1,5-Anhydroglucitol in Over 2000 Patients With Type 2 Diabetes.." Journal of Clinical Endocrinology & Metabolism. Vol. 94, no. 5. (January 2009.): 1689-94.
Dungan KM, Braithwaite SS, Preiser JC. "Stress Hyperglycemia." Lancet. Vol. 373, no. 9677. (January 2009.): 1798-.
Fabiato K, Buse JB, Duclos M, Largay J, Izlar C, Oâ€™Connell T, Stallings J, Dungan KM. "Clinical Experience with CGM Use in Adults." Diabetes Technology & Therapeutics. Vol. 11, no. S1. (January 2009.): 93-103.
Dungan KM, Buse JB, Ratner R. "Effects of Therapy in Type 1 and Type 2 Diabetes Mellitus with a Peptide Derived from Islet Neogenesis Associated Protein (INGAP).." Diabetes Metabolism Research and Reviews. Vol. 25, no. 6. (September 2009.): 558-565.
Herman WH, Buse JB, Arakaki RF, Dungan KM, Jiang HH, Jacobson FG, Fahrbach JL. "Concomitant Oral Antihyperglycemic Agent Use is Associated with Treatment Outcomes after Insulin Initiation." Endocrine Practice. Vol. 17, no. 4. (January 2011.): 563-567.
Alghothani N, Dungan K. "The Effect of Glycemic Variability (GV) on Counterregulatory (CR) Hormone Responses to Hypoglycemia in Young Children and Adolescents with Type 1 Diabetes.." J Diabetes Tech Ther. Vol. 13, no. 11. (January 2011.): 1085-1089.
Dungan KM, Osei K, Nagaraja HN, Schuster DS, Binkley P.. "Relationship between glycemic control and readmission rates in patients hospitalized with congestive heart failure during the implementation of hospital-wide initiatives." Endocrine Practice. Vol. 17, no. 5. (September 2011.): 753-758.
Dungan KM, Schuster DS, Hall C, Osei K. "The Effect of Diabetes Status on the Evaluation of an Algorithm Containing Detemir and Flexible Mealtime Aspart for in Stable Post-Cardiac Surgery Patients Requiring Intravenous Insulin.." Diabetes Obesity & Metabolism. Vol. 13, no. 12. (January 2011.): 1130-1135.
Dungan KM, Hall C, Schuster DP, Osei K.. "Comparison of three algorithms for basal insulin in transitioning stable post-cardiothoracic surgery patients from intravenous to subcutaneous insulin, Endocrine Practice." Endocrine Practice. Vol. 17, no. 5. (January 2011.): 753-758.
Dungan KM, Binkley P, Nagaraja HN, Schuster DS, Osei K. "Assessment of glycemic control and variability in patients hospitalized with congestive heart failure during the implementation of hospital-wide initiatives and effects on mortality." Diabetes Metabolism Research & Reviews. Vol. 27, no. 1. (January 2011.): 85-93.
Dungan KM, Miele A, Weiland K.. "Accuracy of retrospective continuous glucose monitoring in patients with decompensated heart failure." Journal of Diabetes Science & Technology. Vol. 6, no. 4. (July 2012.): 884-91.
Dungan KM. "Predicting outcomes and assessing control with alternate glycemic markers.." Diabetes Technol Ther. Vol. 14, no. 9. (September 2012.): 749-52.
Dungan KM, Buse JB, Herman WH, Arakaki RF, Jiang H, Jacobsen JG, Fahrbach JL. "Potential for Use of 1,5-Anhydroglucitol When Initiating Insulin Therapy in Patients with Type 2 Diabetes and Suboptimal Control with Oral Antidiabetic Drugs." Diabetes Research & Clinical Practice. Vol. 6, no. 3. (June 2012.): e66-9.
Miele A, Weiland K, Jappe J, Dungan KM. "Use of a standardized interpretation form for retrospective continuous glucose monitoring." Diabetes Technology & Therapeutics. -.
Kathleen Dungan, Jared Moore. ""Glycemic variability and glycemic control in the acutely ill cardiac patient."." Heart Failure Clinics. -.
|January 2006||Dr. Kathleen Marie Dungan, Buse JB, Largay J, Kelly MM, Button EA, Kato S, Wittlin S.."1,5-Anhydroglucitol assay as an adjunct to hemoglobin A1c for measurement of postprandial hyperglycemia." .|
|January 2006||Dungan KM, Buse JB, Largay J, Kelly MM, Button EA, Kato S, Wittlin S.."Serum 1,5-Anhydroglucitol (1,5-AG) as an Adjunct to A1C Testing – Reflecting Both Postprandial Hyperglycemia and Short-Term Glycemic Control (385P)" .|
|January 2007||Dr. Kathleen Marie Dungan, Guster T, Buse JB."A comparison of NMR and chemical measures of lipids and lipoproteins in the fasting and nonfasting states in patients with type 2 diabetes." Chicago, IL.|
|June 2008||Schuster DP, Hall C, Dungan K, Kuehn L, Gerkin A, VanBuren L, Rogers P."The Use of Information Technology to Change Diabetes Management in a Large Academic Cente" San Francisco.|
|June 2008||Schuster DP, Hall C, Dungan K, Ali N, Vermillion B."Use of Hospital-Wide Nurse-Managed Insulin Drip Guidelines in a Large Academic Center." San Francisco.|
|June 2008||Dungan KM, Schuster D, Binkley P, Osei K.."Relationships between glycemic control and outcomes in patients hospitalized with congestive heart failure." San Francisco.|
|June 2008||Dungan KM, Fahrbach J, Jiang H, Martin S."DURABLE Trial: Baseline 1,5 Anhydroglucitol (1,5-AG) in a Large, Diverse Racial and Ethnic T2D Population" San Francisco.|
|January 2010||Alghothani N, Dungan, KM."The effect of glycemic variability (GV) on counterregulatory (CR) hormone responses to hypoglycemia in young children and adolescents with type 1 diabetes." Orlando.|
|January 2010||Gilligan P, Zappe J, Dungan KM."Efficacy of Subcutaneous Continuous Insulin Infusion Devices among Patients with or without Complications" Orlando.|
|January 2010||Dungan KM, Buse JB, Herman WH, Arakaki RF, Jiang H, Jacobson JG, Fahrbach JL."Utility of 1,5-anhydroglucitol (1,5AG) for guiding insulin therapy in type 2 diabetes (T2D) patients (Pts) with suboptimal control on oral antidiabetic agents (OADs)." Orlando.|
|January 2011||Dungan KM, Moore J, Schuster D, Binkley P, Osei K.."Effect of Intravenous Insulin on Glycemic Variability in Patients Hospitalized with Heart Failure" .|
|January 2011||Dungan KM, Moore J, Schuster D, Binkley P, Osei K."Effect of Intravenous Insulin on Glycemic Variability in Patients Hospitalized with Heart Failure" .|
|January 2011||Dungan KM, Gavrilina T, Hall C, Lorenzo A, Schuster D."Safety and efficacy of a universal nursing-run intravenous insulin guideline on medical and surgical wards." San Diego. : 1107|
|January 2011||Dungan KM, Gavrillina T, Hall C, Lorenzo A, Schuster D."Safety and efficacy of a universal nursing-run intravenous insulin guideline on medical and surgical wards" .|
|January 2011||DARA P. SCHUSTER, KATHLEEN DUNGAN, CHRIS HALL, CARA HARRIS, SHARON LYONS."Managing Diabetes in a Large Academic Center: Is It Safe, Sustainable?" .|
|January 2011||WEN HAN, TRISHA ZEIDAN, TYLER FULLER, DARA SCHUSTER, KATHLEEN DUNGAN."Determinants of the Accuracy of Continuous Glucose Monitoring in Non-Critically Ill Patients with or without Heart Failure Receiving Insulin Infusion" San Diego.|
|January 2011||Han W, Zeidan T, Fuller T, Schuster D, Dungan KM."Determinants of the Accuracy of Continuous Glucose Monitoring in Non-Critically Ill Patients with or without Heart Failure Receiving Insulin Infusion." .|
|June 2012||Dungan KM, Kulkarni M, Lyons S, Mapes S, Harris C, Black D, Rose T."Diabetes Control, Compliance and Continuity (DC3): A Transition Program for Improved Outpatient Diabetes Care after Hospital Discharge" Bethesda.|
|June 2012||Baldwin D, Kinnare K, Draznin B, Seggelke SA, Krinsley JS, Gandhi S, Bhalani V, Braithwaite SS, Srinivasan C, Heintz K, Dungan KM, Bernard J, Edgren A, Diaz J, Aronson M, Barnosky A, Emanuelle M."Insulin treatment of hyperglycemia in hospitalized patients receiving total parenteral nutrition (TPN)." Bethesda.|
|Dungan K, Lyons S, Kulkarni M, Harris C, Mapes S, Black D, Rose T, Schuster D."The Diabetes Control, Compliance and Continuity Hospital Discharge Program" .|
Eric Button, Kathleen Dungan, Shuhei Kato, John Buse, Steve Wittlin. "WO2006116083) THE 1, 5-ANHYDROGLUCITOL (1, 5-AG) ASSAY AND A1C/1. 5-AG ASSAY COMBINATION FOR MEASURING BLOOD GLUCOSE EXCURSIONS IN GENERAL AND POSTPRANDIAL HYPERGLYCEMIA IN DIABETIC PATIENTS." GlycoMarkFiled April 2006.
"Multiple regional lectures outside OSU (see Teaching)." Presented at Variable, . (August 2006)
"1,5-Anhydroglucitol (Glycomark): A short-term marker of glycemic control." Presented at American Diabetes Association 67th Scientific Sessions, San Francisco, CA. (June 2008)
"â€œReview of Pharmacology and Current Literature Related to Glucose Monitors and Drugs Containing Select Sugarsâ€�." Presented at HepaGamB Think Tank, Fort Lauderdale, FL, US|USA. (May 2009)
"The story on pancreatitis and c-cell hyperplasia." Presented at American Diabetes Association 70th Annual Scientific Sessions, Orlando. (June 2010)
""Insulin Delivery Systems and Analysis"." Presented at American Diabetes Association 70th Scientific Sessions, Orlando. (June 2010)
"Relationship between glycemic control and hospital." Presented at Diabetes Technology Society 10th Annual Diabetes Technology Meeting, Bethesda, MD, US|USA. (November 2010)
"Metabolic biomarkers for use in clinical diabetology." Presented at Rachmiel Levine Diabetes and Obesity Symposium, . (March 2011)
|2011 - present||CCTS DSMB. OSU Center for Clinical and Translational Science.|
|2010 - 2011||Grant Review. Italian Ministry of Health.|